Table 1.

The in vitro inhibitory activity of tested compounds against tumor cell lines expressed as IC₅₀ values (μM) ± standard deviation from six replicates.

Tested Compounds	Tumor Cell Lines
	MCF-7	HepG2
9a	29.11 ± 0.21	25.42 ± 0.21
9b	8.67 ± 0.30	2.94 ± 0.12
9c	7.72 ± 0.18	17.60 ± 0.23
9d	22.40 ± 0.20	16.13 ± 0.21
9e	22.94 ± 0.18	21.72 ± 0.14
9f	38.21 ± 0.16	43.43 ± 0.19
9g	19.72 ± 0.20	10.71 ± 0.27
12a	3.4 ± 0.23	1.19 ± 0.07
12b	22.5 ± 0.24	27.90 ± 0.24
12c	20.1 ± 0.12	29.41± 0.07
22a	37.7 ± 0.11	27.94 ± 0.13
22d	39.9 ± 0.07	43.62 ± 0.14
Doxorubicin	0.46 ± 0.21	0.42 ± 0.22